I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 11 studies | 19% ± 2% | |
| endothelial cell | 7 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 20% ± 5% | |
| CD8-positive, alpha-beta T cell | 6 studies | 19% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 21% ± 5% | |
| regulatory T cell | 5 studies | 19% ± 2% | |
| epithelial cell | 4 studies | 32% ± 8% | |
| ciliated cell | 4 studies | 24% ± 5% | |
| plasmacytoid dendritic cell | 4 studies | 18% ± 2% | |
| gamma-delta T cell | 4 studies | 25% ± 10% | |
| classical monocyte | 3 studies | 18% ± 2% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| neuron | 3 studies | 24% ± 3% | |
| GABAergic neuron | 3 studies | 39% ± 5% | |
| glutamatergic neuron | 3 studies | 51% ± 5% | |
| basal cell | 3 studies | 24% ± 4% | |
| double negative thymocyte | 3 studies | 23% ± 6% | |
| mucosal invariant T cell | 3 studies | 18% ± 3% | |
| astrocyte | 3 studies | 19% ± 3% |
